Days
Hours
Minutes
Seconds
-40%
on all subscriptions*
Last days
Enjoy this offer
* See conditions under "Our services"

Valuation: Colinz Laboratories Limited

Market Cap 112M 1.19M 1.02M 941K 883K 1.66M 1.67M 11.12M 4.34M 54.9M 4.45M 4.36M 190M P/E Ratio 2024
19.5x
P/E Ratio 2025 36.8x
Enterprise Value 63.01M 667K 575K 529K 496K 932K 941K 6.25M 2.44M 30.85M 2.5M 2.45M 107M EV / Sales 2024
0.43x
EV / Sales 2025 2.04x
Free-Float
31.44%
Yield 2024 *
-
Yield 2025 -
05-25 Padam Dugar, Annjana Dugar, Likhitta Dugar and Antariksh Dugar acquired 15.01% stake in Colinz Laboratories Limited. CI
04-29 Colinz Laboratories Limited Reports Earnings Results for the Fourth Quarter and Full Year Ended March 31, 2026 CI
01-24 Colinz Laboratories Limited Reports Earnings Results for the Third Quarter and Nine Months Ended December 31, 2025 CI
01-17 Hilsun Foods And Drugs Private Limited signed a letter of intent to acquire Factory Building, Factory Machinery, & Factory Land of Colinz Laboratories Limited for INR 40 million. CI
11-27 Colinz Laboratories Limited Appoints Falguni Kumawat as Company Secretary and Compliance Officer, with Effect from 1 December, 2025 CI
11-08 Colinz Laboratories Limited Announces of Demise Dr. Mani L.S., Founder Director, Company Secretary and Compliance Officer on 7 November 2025 CI
11-03 Colinz Laboratories Limited Reports Earnings Results for the Second Quarter and Six Months Ended September 30, 2025 CI
31/07/25 Colinz Laboratories Limited Reports Earnings Results for the First Quarter Ended June 30, 2025 CI
21/05/25 Colinz Laboratories Limited Appoints Swapnil Jayesh Madiyar as Additional Director, Effective from May 16, 2025 CI
16/05/25 Colinz Laboratories Limited Reports Earnings Results for the Full Year Ended March 31, 2025 CI
04/03/25 Colinz Laboratories Limited Reports Earnings Results for the Third Quarter and Nine Months Ended December 31, 2024 CI
30/10/24 Colinz Laboratories Limited Reports Earnings Results for the Second Quarter and Six Months Ended September 30, 2024 CI
01/10/24 Colinz Laboratories Limited Approves Board Appointments CI
1 day+2.91%
1 week-8.73%
Current month+5.24%
1 month+23.67%
3 months+36.02%
6 months+22.33%
Current year+4.92%
1 week 53.11
Extreme 53.11
64.89
1 month 42
Extreme 42
64.97
Current year 39.31
Extreme 39.31
87.91
1 year 36.11
Extreme 36.11
87.91
3 years 33.35
Extreme 33.35
88.7
5 years 14.61
Extreme 14.61
88.7
10 years 4.8
Extreme 4.8
88.7
Manager TitleAgeSince
Chief Executive Officer 73 -
Director of Finance/CFO - 20/05/2019
Compliance Officer - 01/12/2025
Director TitleAgeSince
Director/Board Member 73 26/11/1990
Director/Board Member 33 08/08/2024
Director/Board Member 76 08/08/2024
Change 5-day change 1-year change 3-year change Capi.($)
+2.91%-8.73%+1.46%+42.46% 1.45M
-0.09%+1.34%+7.00%+83.03% 45.63B
-0.10%-3.31%+41.08%+82.87% 33.53B
-0.58%-1.43%-8.23%+41.14% 11.81B
-1.50%-0.08%+11.61%+104.40% 11.69B
+1.54%+3.53%+40.43%+135.71% 9.12B
+1.59%+1.68%+20.24%+44.80% 7.16B
-0.02%+1.80%+45.10%-15.41% 6.49B
-0.79%-0.44%+29.15%+238.32% 6.45B
+0.06%-2.97%-43.02%-3.42% 5.16B
Average +0.58%-1.04%+14.48%+75.39% 13.7B
Weighted average by Cap. +0.13%-0.17%+18.30%+82.11%

Financials

2024 2025
Net sales 70.3M 744K 641K 590K 554K 1.04M 1.05M 6.98M 2.72M 34.42M 2.79M 2.73M 119M 65.28M 691K 595K 548K 514K 965K 975K 6.48M 2.53M 31.97M 2.59M 2.54M 111M
Net income 4.87M 51.5K 44.39K 40.85K 38.32K 71.99K 72.71K 483K 189K 2.38M 193K 189K 8.25M 4.97M 52.55K 45.29K 41.68K 39.1K 73.45K 74.18K 493K 192K 2.43M 197K 193K 8.42M
Net Debt -64.3M -680K -586K -540K -506K -951K -961K -6.38M -2.49M -31.49M -2.55M -2.5M -109M -49.09M -519K -448K -412K -387K -726K -733K -4.87M -1.9M -24.04M -1.95M -1.91M -83.19M
Logo Colinz Laboratories Limited
Colinz Laboratories Ltd. is an India-based company that is engaged in the manufacturing and marketing of pharmaceutical formulations, particularly in the gynecological sector. It is engaged in the manufacturing and marketing various allopathic, ayurvedic, and nutraceuticals pharmaceutical formulations in the dosage forms of tablets, capsules, liquid orals and ointments, among others. The company has specialized products for Gynecology, cardiology, gastroenterology, and others. Its oncology products include imitinib, erlotinib, letrozole, exemestane, bortezomib, fludarabine phosphate, and doxorubicin. Its Ayurvedic products include anti-diarrhoeals, anti-pyretics, anti-inflammatories, anti-spasmodics, cough syrups, appetite stimulating agents, and memory boosters. Its nutraceuticals products include spirulina tabs/caps, spirulina with vitamins & minerals, omega 3 fatty acid caps in softgel, codliver oil with vitamin caps in soft gel, collagen, and glucosamine & chondroitin tabs.
Employees
65
Date Price Change Volume
15/06/26 56.27 +2.91% 209
12/06/26 54.68 +2.88% 3,172
11/06/26 53.15 -4.92% 3,129
10/06/26 55.90 -4.96% 1,941
09/06/26 58.82 -4.98% 2,863
  1. Stock Market
  2. Stocks
  3. COLINZ6 Stock